106 related articles for article (PubMed ID: 11495099)
1. Topiramate in posttraumatic stress disorder: preliminary clinical observations.
Berlant JL
J Clin Psychiatry; 2001; 62 Suppl 17():60-3. PubMed ID: 11495099
[TBL] [Abstract][Full Text] [Related]
2. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.
Berlant J; van Kammen DP
J Clin Psychiatry; 2002 Jan; 63(1):15-20. PubMed ID: 11838620
[TBL] [Abstract][Full Text] [Related]
3. Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder.
Berlant JL
BMC Psychiatry; 2004 Aug; 4():24. PubMed ID: 15315714
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder.
Lindley SE; Carlson EB; Hill K
J Clin Psychopharmacol; 2007 Dec; 27(6):677-81. PubMed ID: 18004136
[TBL] [Abstract][Full Text] [Related]
5. Topiramate in combat-related posttraumatic stress disorder.
Alderman CP; McCarthy LC; Condon JT; Marwood AC; Fuller JR
Ann Pharmacother; 2009 Apr; 43(4):635-41. PubMed ID: 19336652
[TBL] [Abstract][Full Text] [Related]
6. Treatment of civilian and combat-related posttraumatic stress disorder with topiramate.
Andrus MR; Gilbert E
Ann Pharmacother; 2010 Nov; 44(11):1810-6. PubMed ID: 20923947
[TBL] [Abstract][Full Text] [Related]
7. [Topiramate for the treatment of post traumatic stress disorder. A case study].
Aalbersberg CF; Mulder JM
Tijdschr Psychiatr; 2006; 48(6):487-91. PubMed ID: 16956009
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder.
Watts BV; Schnurr PP; Mayo L; Young-Xu Y; Weeks WB; Friedman MJ
J Clin Psychiatry; 2013 Jun; 74(6):e541-50. PubMed ID: 23842024
[TBL] [Abstract][Full Text] [Related]
9. AMPA blockade may be the mechanism underlying the efficacy of topiramate in PTSD.
Zullino DF; Krenz S; Besson J
J Clin Psychiatry; 2003 Feb; 64(2):219-20. PubMed ID: 12633137
[No Abstract] [Full Text] [Related]
10. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD.
Yeh MS; Mari JJ; Costa MC; Andreoli SB; Bressan RA; Mello MF
CNS Neurosci Ther; 2011 Oct; 17(5):305-10. PubMed ID: 21554564
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder.
Mello MF; Yeh MS; Barbosa Neto J; Braga LL; Fiks JP; Mendes DD; Moriyama TS; Valente NL; Costa MC; Mattos P; Bressan RA; Andreoli SB; Mari JJ
BMC Psychiatry; 2009 May; 9():28. PubMed ID: 19480669
[TBL] [Abstract][Full Text] [Related]
12. Posttraumatic intrusive symptoms across psychiatric disorders.
Bryant RA; O'Donnell ML; Creamer M; McFarlane AC; Silove D
J Psychiatr Res; 2011 Jun; 45(6):842-7. PubMed ID: 21159353
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.
Jetly R; Heber A; Fraser G; Boisvert D
Psychoneuroendocrinology; 2015 Jan; 51():585-8. PubMed ID: 25467221
[TBL] [Abstract][Full Text] [Related]
14. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
[TBL] [Abstract][Full Text] [Related]
15. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
Auxéméry Y
Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
[TBL] [Abstract][Full Text] [Related]
16. Imagery rescripting and exposure group treatment of posttraumatic nightmares in Veterans with PTSD.
Long ME; Hammons ME; Davis JL; Frueh BC; Khan MM; Elhai JD; Teng EJ
J Anxiety Disord; 2011 May; 25(4):531-5. PubMed ID: 21354767
[TBL] [Abstract][Full Text] [Related]
17. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
Chengappa KN; Gershon S; Levine J
Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study.
Tucker P; Trautman RP; Wyatt DB; Thompson J; Wu SC; Capece JA; Rosenthal NR
J Clin Psychiatry; 2007 Feb; 68(2):201-6. PubMed ID: 17335317
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapeutic treatment of nightmares and insomnia in posttraumatic stress disorder: an overview of the literature.
van Liempt S; Vermetten E; Geuze E; Westenberg H
Ann N Y Acad Sci; 2006 Jul; 1071():502-7. PubMed ID: 16891608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
